other_material
confidence high
sentiment positive
materiality 0.70
BullFrog AI secures first commercial agreement with top 5 pharma; runway into late 2027
BullFrog AI Holdings, Inc.
- First commercial feasibility agreement with a top 5 global pharma for bfLEAP platform in MDD (market >$8B).
- Financing in late March 2026 provides runway into late 2027; stockholders' equity >$2.5M meets Nasdaq standard.
- Launched bfARENAS platform in March 2026, completing end-to-end AI platform for pharma R&D.
- Ongoing Lieber Institute collaboration grants access to >2,800 human brain samples for neuropsychiatric targets.